 
Class of 2023
 Go Back | | Session Title: | | Psychopharmacology | | | Teaching Hours: | | Teaching and Learning Methods | Total Scheduled Hours = 2
Lecture = 2 | | Description: | | | | Keywords: |
| Blueprint ID | Learning Objectives | | 10615 | Review the monoamine hypothesis of depression and how this relates to the proposed mechanism of action of antidepressants. | | 10616 | Review the dopamine dysregulation theory as it relates to the proposed etiology of symptoms of schizophrenia and the mechanism by which antipsychotics may treat symptoms and/or cause certain adverse effects. | | 10617 | Describe the basic pharmacologic profiles (including what neurotransmitters they affect, what reuptake pumps and/or enzymes they may interact with, and what receptors they may interact with either directly, or indirectly through the facilitation of neurotransmitters) of the seven main classes of antidepressants (i.e. TCAs, SSRIs, SNRIs, NDRIs, SARIs, MAOIs, and NaSSAs). | | 10618 | List the generic names of the more common antidepressants within each main class listed above (note: these can be found in the lecture handout). | | 10619 | Describe the basic pharmacologic profiles (including what neurotransmitters they affect and what receptors they may interact with either directly, or indirectly through the facilitation of neurotransmitters) of the three main classes of antipsychotics (i.e. First Generation antipsychotics-including low, moderate and high potency agents; Second Generation Antipsychotics, and the Third Generation Antipsychotic, aripiprazole). | | 10620 | Describe the potential effects that arise as a result of an antidepressant’s or antipsychotic’s pharmacological profile i.e. what happens as a consequence of the drug’s potential interactions (either directly or indirectly through the facilitation of neurotransmitters) with a number of serotonergic, dopaminergic, adrenergic, histaminic, and muscarinic receptors; as well as with reuptake pumps and/or enzymes. | | 10621 | Apply knowledge of an antidepressant’s or antipsychotic’s pharmacological profile to determine which agent might be best suited for an individual patient scenario. | | 10622 | Apply knowledge of an antidepressant’s or antipsychotic’s pharmacological profile to determine how to switch medications safely to avoid serious adverse drug reactions. | | 10623 | Apply knowledge of an antidepressant’s pharmacological profile to determine what combinations of these medications might be reasonable and which should be avoided. | | |
| Blueprint ID | Course Goals | | 7023 | Integrate basic and clinical sciences as they relate to common clinical encounters and patient symptoms
Linked Program Competencies
To This Course Goal: me-6 | | 11989 | Identify health care resources available for the investigation, diagnosis, treatment and management of the patient
Linked Program Competencies
To This Course Goal: me-3 me-4 me-5 me-6 | | 11991 | Identify risk factors for illness and disease prevention
Linked Program Competencies
To This Course Goal: ha-1 ha-2 | | 11992 | Collect and synthesize accurate and relevant information related to common clinical encounters and patient symptoms
Linked Program Competencies
To This Course Goal: me-1 me-2 me-3 me-4 me-5 me-6 cm-2 | | me-6 | Medical Expert
Apply knowledge of the clinical, socio-behavioural, and fundamental biomedical sciences relevant to a clinical problem. | | me-3 | Medical Expert
Formulate an initial plan of appropriate diagnostic and therapeutic procedures relevant to the patient’s presentation. | | me-4 | Medical Expert
Develop a differential diagnosis and key clinical problem list following assessment of a patient. | | me-5 | Medical Expert
Develop a management plan for key clinical problems following assessment of a patient. | | ha-1 | Health Advocate
Identify the important determinants of health, risk factors for illness, interaction between the population and their physical, biological and social environment, and personal attributes. | | ha-2 | Health Advocate
Identify public policies and trends that affect health locally, nationally, and globally, and barriers to access for populations, including persons with disabilities, the underserved and the marginalized. | | me-1 | Medical Expert
Perform a complete and accurate patient-centred history appropriate to the patient’s presentation. | | me-2 | Medical Expert
Perform a complete and accurate physical examination appropriate to the patient’s presentation. | | cm-2 | Communicator
Collect and synthesize accurate and relevant information, incorporating perspectives from patients and their families, colleagues and other health care professionals. |
|